Publicaciones (22) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. Antimicrobial susceptibility of Listeria monocytogenes isolated from food and clinical cases in Navarra, Spain

    Journal of Food Protection, Vol. 70, Núm. 10, pp. 2402-2406

  2. Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis

    Vaccine, Vol. 25, Núm. 15, pp. 2858-2862

  3. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles

    Vaccine, Vol. 25, Núm. 48, pp. 8123-8132

  4. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections

    Expert Opinion on Drug Delivery, Vol. 4, Núm. 6, pp. 677-688

  5. Biotechnological war against biofilms. Could phages mean the end of device-related infections?

    International Journal of Artificial Organs, Vol. 30, Núm. 9, pp. 805-812

  6. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence

    Infection and Immunity, Vol. 75, Núm. 10, pp. 4867-4874

  7. Comparison of multiple-locus variable-number tandem-repeat analysis with other PCR-based methods for typing Brucella suis isolates

    Journal of Clinical Microbiology, Vol. 45, Núm. 12, pp. 4070-4072

  8. Enterovirus 75, un nuevo virus patógeno en nuestro medio

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 9, pp. 566-569

  9. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

  10. Gamma interferon loaded onto albumin nanoparticles: In vitro and in vivo activities against Brucella abortus

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 4, pp. 1310-1314

  11. Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens

    Vaccine, Vol. 25, Núm. 29, pp. 5263-5271

  12. Intradermal immunization with ovalbumin-loaded poly-ε-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice

    Clinical and Experimental Allergy, Vol. 37, Núm. 2, pp. 287-295

  13. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: Thermodynamic, biophysical and microbiological analysis

    Biochemical Journal, Vol. 406, Núm. 2, pp. 297-307

  14. Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo

    International Journal of Cancer, Vol. 121, Núm. 6, pp. 1197-1204

  15. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)- glucosamine

    Infection and Immunity, Vol. 75, Núm. 7, pp. 3406-3413

  16. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

    Leukemia and Lymphoma, Vol. 48, Núm. 12, pp. 2461-2464

  17. Poly(D,L-lactide-coglycolide) particles containing gentamicin: Pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice

    Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 4, pp. 1185-1190

  18. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 18, pp. 7528-7533

  19. Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice

    Vaccine, Vol. 25, Núm. 22, pp. 4410-4419

  20. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against gram-negative pathogens

    Journal of Biological Chemistry, Vol. 282, Núm. 20, pp. 14719-14728